Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 362 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Electrocardiogram (ECG) Clear all

Conditions: Congenital Disorders
Interventions: Epinephrine; Drug
Lead sponsor: Emory University; Other
Eligibility: 3 Years to 18 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Aortic Stenosis, Diastolic Dysfunction
Interventions: AI-ECG Dashboard, Point of care ultrasound (POCUS); Device · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 60 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Systemic Lupus Erythematosus, Healthy Participants
Interventions: BMS-986165, Moxifloxacin, Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Chest Pain, Acute Myocardial Infarction
Interventions: Electronic risk alerts; Other
Lead sponsor: Harvard Vanguard Medical Associates; Other
Eligibility: 30 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Boston, Massachusetts • Newton, Massachusetts

Conditions: Gynecologic Cancer, Gynecologic Neoplasms, Peritoneal Carcinomatosis, Peritoneal Neoplasms, Ovarian Cancer, Ovarian Neoplasms, Colorectal Cancer, Colorectal Neoplasms, Appendiceal Cancer, Appendiceal Neoplasms, Cholangiocarcinoma, Breast Cancer
Interventions: Paclitaxel, Nilotinib, ECG, CT Scan CAP, Laparoscopy, Peritoneal biopsies + ascites washings; Drug · Diagnostic Test · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sedation for Non-Emergent Upper and/or Lower Endoscopy
Interventions: Passive monitoring with pulse-oximetry, NIBP and ECG; Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Regional Anesthesia Morbidity
Interventions: Electrocardiogram; Diagnostic Test
Lead sponsor: Senthil G. Krishna; Other
Eligibility: Up to 18 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Depressive Symptoms, Stress Disorder, Acute, Prolonged Grief Disorder, Alcohol Abuse, Stress Disorders, Post-Traumatic
Interventions: Accelerated Resolution Therapy; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Healthy
Interventions: Canagliflozin (JNJ-28431754), Placebo, Moxifloxacin; Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Asymptomatic Left Ventricular Systolic Dysfunction (Disorder), Heart Failure
Interventions: AI-enabled ECG-based Screening Tool; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Arrhythmias, Cardiac, Cardiac Arrest, Cardiac Arrythmias
Interventions: Neural Network Classifier; Other
Lead sponsor: Scripps Clinic; Other
Eligibility: Not listed
Enrollment: 25,458 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Influenza, Human
Interventions: 600 mg zanamivir + moxifloxacin placebo, 1200 mg zanamivir + moxifloxacin placebo, zanamivir placebo + moxifloxacin placebo, zanamivir placebo + 400 mg moxifloxacin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Cardiomyopathy
Interventions: KardiaRx ECG Screening and AI interpretation of ECG; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Myeloid Leukemia
Interventions: Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy, Cytarabine, Daunorubicin, Electrocardiography, Pemigatinib; Procedure · Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Portland, Oregon • Dallas, Texas

Conditions: Valvular Heart Disease
Interventions: Not listed
Lead sponsor: Cardiovascular Research Foundation, New York; Other
Eligibility: 65 Years to 85 Years
Enrollment: 2,870 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Atherosclerosis, Chronic Granulomatous Disease (CGD)
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: High-risk Cardiac Patients
Interventions: Willem AI ECG assessment; Device
Lead sponsor: Idoven 1903 S.L.; Industry
Eligibility: 18 Years and older
Enrollment: 200,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation, Persistent
Interventions: active taVNS, sham-taVNS; Device
Lead sponsor: Burrell College of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Las Cruces, New Mexico

Conditions: Syncope, Pre-syncope, Atrial Fibrillation, Supraventricular Tachycardia
Interventions: Standard Holter/Investigational patch; Device
Lead sponsor: Seattle Institute for Cardiac Research; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Chicago, Illinois • Enumclaw, Washington

Conditions: Heart Failure, Arrhythmias, Cardiac, Health Care Utilization
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4,163 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hyperkalemia, Chronic Kidney Disease (Stage 3-4)
Interventions: AK+ Guard™ ECG Application; Device
Lead sponsor: AccurKardia, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Eatontown, New Jersey

Conditions: Glioblastoma Multiforme (GBM), Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions: 203Pb-RMX-VHPIB injection, SPECT/CT Imaging; Drug · Diagnostic Test
Lead sponsor: Radiomedix, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypoxia
Interventions: Chest Worn Pulse Oximeter; Device
Lead sponsor: Perin Health Devices; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sleep Apnea Syndromes
Interventions: CPAP; Device
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients

AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

Risk Score Alerts for Chest Pain Care

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Evaluation of Cardiorespiratory Events in Subjects Undergoing an Upper and/or Lower Endoscopy Under Current Sedation Practices

Caudal Blockade and Electrocardiographic Changes

Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART)

A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

ECG AI-Guided Screening for Low Ejection Fraction

Development of a Novel Convolution Neural Network for Arrhythmia Classification

A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

AI-SCREENDCM Decentralized Clinical Trial - Pilot Study

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

Effect of taVNS on Heart Rate in Persistent Atrial Fibrillation

The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)

Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App

AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Pulse Oximeter Validation Study for the Perin Health Patch

Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)